Dr. Mexal joined Ambry Genetics in 2009. As VP of Clinical Operations, she focuses on the continued operational excellence and innovation of Ambry’s clinical laboratory, including advancing test turnaround times and quality. She graduated with honors from the University of New Mexico with a B.S. in Biology and with a Ph.D. in Human Medical Genetics from the University of Colorado Anschutz Medical Campus. Dr. Mexal completed her post-doctoral research at the University of Colorado at Boulder Institute for Behavioral Genetics. Prior to joining Ambry, Dr. Mexal was active in neurogenetics research and pharmaceutical compound screening for over a decade in industry and academic laboratories. She has published numerous articles on the genetics of schizophrenia and tobacco addiction in human and animal models. Dr. Mexal is licensed by ASCP and the state of California as a Clinical Genetic Molecular Biologist.